Altfest L J & CO Inc Biomarin Pharmaceutical Inc Transaction History

Altfest L J & CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$80.93 - $108.63 $1,699 - $2,281	-21 Reduced 0.63%	3,339 $346,000
Q3 2022 Nov 15, 2022	BUY	$82.16 - $96.94 $276,057 - $325,718	3,360 New	3,360 $285,000
Q4 2021 Jan 24, 2022	SELL	$71.72 - $91.47 $255,108 - $325,358	-3,557 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$74.77 - $85.47 $123,819 - $141,538	-1,656 Reduced 31.77%	3,557 $275,000
Q2 2021 Jul 28, 2021	SELL	$75.51 - $84.79 $70,450 - $79,109	-933 Reduced 15.18%	5,213 $435,000
Q1 2021 May 07, 2021	SELL	$74.73 - $90.69 $37,066 - $44,982	-496 Reduced 7.47%	6,146 $464,000
Q4 2020 Jan 21, 2021	BUY	$72.61 - $90.2 $6,897 - $8,569	95 Added 1.45%	6,642 $582,000
Q3 2020 Oct 29, 2020	BUY	$71.87 - $131.03 $165,444 - $301,631	2,302 Added 54.23%	6,547 $498,000
Q2 2020 Jul 21, 2020	BUY	$79.55 - $124.22 $138,973 - $217,012	1,747 Added 69.94%	4,245 $524,000
Q1 2020 Apr 13, 2020	BUY	$71.37 - $96.85 $178,282 - $241,931	2,498 New	2,498 $211,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Altfest L J & CO Inc with notifications on news.